Post-approval studies (Phase 4)Looking for participantsNCT07323524What this trial is testingDapagliflozin in Active Lupus NephritisWho this might be right forLupus Nephritis (LN) Brigham and Women's Hospital 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT06656962What this trial is testingThe Efficacy and Safety of Treatment with Telitacicept in Antineutrophil Cytoplasmic Antibody-associated Nephritis (AAGN)Who this might be right forAntineutrophil Cytoplasmic Antibody (ANCA)-associated Nephritis (AAGN) Renmin Hospital of Wuhan University 15
Not applicableWithdrawnNCT00908986What this trial is testingOpen Label Pilot Trial of Rituximab in Lupus Membranous NephritisWho this might be right forLupus Nephritis Northwell Health
Testing effectiveness (Phase 2)Looking for participantsNCT06419205What this trial is testingEvaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3GWho this might be right forIgA NephropathyLupus Nephritis (LN)C3 (Complement Component 3) Glomerulopathy Akebia Therapeutics 30
Testing effectiveness (Phase 2)Looking for participantsNCT07570862What this trial is testingA Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus NephritisWho this might be right forLupus NephritisSystemic Lupus ErythematosusSLE - Systemic Lupus Erythematosus+2 more Fate Therapeutics 53
Not applicableWithdrawnNCT06508346What this trial is testingStudy of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Children With Refractory Refractory AAVWho this might be right forANCA Associated VasculitisCAR-T Cell Therapy The Children's Hospital of Zhejiang University School of Medicine
Very early researchUnknownNCT05353179What this trial is testingStudy on Pharmacokinetics of Meperizumab Injection and NUCALA® in Healthy Male VolunteersWho this might be right forGranulomatosis With PolyangiitisHemophagocytic Syndrome Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 88
Not applicableUnknownNCT06379646What this trial is testingAn Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune DiseaseWho this might be right forSystemic Lupus ErythematosusSystemic SclerosisInflammatory Myopathy+3 more China Immunotech (Beijing) Biotechnology Co., Ltd. 6
Testing effectiveness (Phase 2)Study completedNCT02472795What this trial is testingClinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-334441 in Subjects With Systemic Lupus ErythematosusWho this might be right forSystemic Lupus Erythematosus Viatris Innovation GmbH 105
Not applicableNot Yet RecruitingNCT06244069What this trial is testingClonal Hematopoiesis in Giant Cell ArteritisWho this might be right forGiant Cell ArteritisTemporal ArteritisClonal Hematopoiesis of Indeterminate Potential+2 more ASST Fatebenefratelli Sacco 326
Not applicableLooking for participantsNCT02257866What this trial is testingStudies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic VasculitisWho this might be right forTakayasu's ArteritisGiant Cell ArteritisPolyarteritis Nodosa+2 more National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 4,000
Very early researchNot Yet RecruitingNCT07266337What this trial is testingCD19/BCMA CAR-T for SLEWho this might be right forSLE - Systemic Lupus Erythematosus Chengdu Ucello Biotechnology Co., Ltd. 24
Early research (Phase 1)Study completedNCT02165345What this trial is testingExtension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic ArthritisWho this might be right forJuvenile Idiopathic Arthritis Hoffmann-La Roche 82
Early research (Phase 1)Study completedNCT04136145What this trial is testingSingle Dose Study to Investigate the Pharmacokinetics (PK) and Safety of Belimumab 200 Milligrams (mg) Intravenous and 200 mg Subcutaneous Via Auto-injector in Chinese Healthy SubjectsWho this might be right forSystemic Lupus Erythematosus GlaxoSmithKline 36
Large-scale testing (Phase 3)Study completedNCT05326841What this trial is testingEffect of Cholecalciferol Supplementation on Disease Activity and Quality of Life of Systemic Lupus Erythematosus Patients .Who this might be right forLupus Erythematosus, SystemicCholecalciferol SupplementationDisease Activity+1 more Dr Cipto Mangunkusumo General Hospital 60
Not applicableUnknownNCT05632029What this trial is testingLaser Acupuncture in Egyptian Systemic Lupus Females With Insulin ResistanceWho this might be right forSystemic Lupus ErythematosusPreDiabetes Cairo University 64
Large-scale testing (Phase 3)Ended earlyNCT00307645What this trial is testingIMPROVE: Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy in ANCA Associated Systemic VasculitisWho this might be right forANCA Associated Systemic Vasculitis Including Wegener'sGranulomatosis and Microscopic Polyangiitis andRenal Limited Vasculitis Assistance Publique - Hôpitaux de Paris 160
Early research (Phase 1)WithdrawnNCT06411639What this trial is testingPharmacokinetics Study of Ianalumab in Chinese Participants With Autoimmune DiseasesWho this might be right forSjogren DiseaseSystemic Lupus Erythematosus Novartis Pharmaceuticals
Not applicableStudy completedNCT05703802What this trial is testingEstablishment of an ELISA for the Recognition of Procalcitonin Variants in Patients With Hyperprocalcitonemia.Who this might be right forSepsisPre-EclampsiaGranulomatosis With Polyangiitis+4 more University Hospital Muenster 30
Testing effectiveness (Phase 2)Study completedNCT03453619What this trial is testingPhase II Study Assessing Safety and Efficacy of APL-2 in GlomerulopathiesWho this might be right forIgA NephropathyLupus NephritisMembranous Nephropathy+2 more Apellis Pharmaceuticals, Inc. 21